Johnson & Johnson JNJ
NYSE JNJ
$266.34 -0.74 (-0.28%)
As of: Sep 10, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Construction in Progress (2010 - 2021)

Johnson & Johnson's (JNJ) quarterly Construction in Progress came in at $4.3 billion in Q1 2021, up 18.67% year-over-year from $3.6 billion in Q1 2020, and up 18.67% quarter-over-quarter from $3.6 billion in Q4 2019.

Analysis

Johnson & Johnson (JNJ) Construction in Progress (2010 - 2021) Analysis & Trends

Johnson & Johnson has disclosed Construction in Progress across 10 years of filings, most recently posting $4.3 billion for Q1 2021.

  • In Q1 2021, Construction in Progress rose 18.67% year-over-year to $4.3 billion; the TTM figure through Jan 2021 stood at $4.3 billion (up 18.67% YoY), while the FY2021 annual figure was $4.3 billion, up 18.67% from the prior year.
  • Construction in Progress came in at $4.3 billion for Q1 2021 at Johnson & Johnson, up from $3.6 billion in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $4.3 billion in Q1 2021 to a low of $3.4 billion in Q1 2017.
  • Average Construction in Progress over 4 years is $3.7 billion, with a median of $3.6 billion recorded in 2019.
  • Year-over-year, Construction in Progress dropped 6.17% in 2019 and gained 18.67% in 2021.
  • Over 4 years, Construction in Progress stood at $3.4 billion in 2017, then gained by 12.41% to $3.9 billion in 2018, then retreated by 6.17% to $3.6 billion in 2019, then advanced by 18.67% to $4.3 billion in 2021.
  • Per Business Quant data, the three most recent Construction in Progress figures were $4.3 billion in Q1 2021, $3.6 billion in Q4 2019, and $3.9 billion in Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn -
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn -
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn -
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn -
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 3, 2021 4.32 Bn
Dec 29, 2019 3.64 Bn
Dec 30, 2018 3.88 Bn
Dec 31, 2017 3.45 Bn
Jan 1, 2017 3.35 Bn
Jan 3, 2016 3.53 Bn
Dec 28, 2014 3.60 Bn
Dec 29, 2013 3.30 Bn
Dec 30, 2012 2.74 Bn
Jan 1, 2012 2.50 Bn
Jan 2, 2011 2.58 Bn
Jan 3, 2010 2.52 Bn